Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tolcapone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alvogen's Generic Tolcapone Receives Approval in the US
    Alvogen's Generic Tolcapone Receives Approval in the US

    29 Jul 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207729

    FDA
    29 Jul 2020
    Share Share
    Kinedexe’s Generic Tolcapone Receives Approval In US
    Kinedexe’s Generic Tolcapone Receives Approval In US

    07 Aug 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210095

    FDA
    07 Aug 2019
    Share Share
    Ingenus Pharms' Generic Tolcapone Receives Approval in US
    Ingenus Pharms' Generic Tolcapone Receives Approval in US

    10 Aug 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208937

    FDA
    10 Aug 2018
    Share Share
    Par Pharm's Generic Tolcapone (100 Mg) Approved in USA For Parkinson’s Disease
    Par Pharm's Generic Tolcapone (100 Mg) Approved in USA For Parkinson’s Disease

    31 Mar 2015

    // Press Release FDA

    https://www.pharmacompass.com/pdf/news/n38.pdf

    Press Release FDA
    31 Mar 2015
    Share Share